Below are the most recent publications written about "beta-Lactamases" by people in Profiles.
-
Bonardi S, Cabassi CS, Fiaccadori E, Cavirani S, Parisi A, Bacci C, Lamperti L, Rega M, Conter M, Marra F, Crippa C, Gambi L, Spadini C, Iannarelli M, Paladini C, Filippin N, Pasquali F. Detection of carbapenemase- and ESBL-producing Klebsiella pneumoniae from bovine bulk milk and comparison with clinical human isolates in Italy. Int J Food Microbiol. 2023 Feb 16; 387:110049.
-
Jimenez A, Fennie K, Munoz-Price LS, Ibrahimou B, Pekovic V, Abbo LM, Martinez O, Rosello G, Sposato K, Doi Y, Trepka MJ. Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: A retrospective cohort study. Am J Infect Control. 2021 10; 49(10):1281-1286.
-
Jimenez A, Fennie K, Munoz-Price LS, Ibrahimou B, Abbo LM, Martinez O, Sposato K, Doi Y, Trepka MJ. Risk factors for the development of infections associated with carbapenemase-producing Enterobacteriaceae among previously colonized patients: A retrospective cohort study. Infect Control Hosp Epidemiol. 2021 06; 42(6):763-766.
-
Bashawri YM, Robins P, Cooper DM, McDonald JE, Jones DL, Williams AP. Impact of Sediment Concentration on the Survival of Wastewater-Derived blaCTX-M-15-Producing E. coli, and the Implications for Dispersal into Estuarine Waters. Int J Environ Res Public Health. 2020 10 19; 17(20).
-
Jimenez A, Trepka MJ, Munoz-Price LS, Pekovic V, Ibrahimou B, Abbo LM, Martinez O, Sposato K, dePascale D, Perez-Cardona A, McElheny CL, Bachman WC, Fowler EL, Doi Y, Fennie K. Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry. Am J Infect Control. 2020 11; 48(11):1341-1347.
-
Holloway AJ, Yu J, Arulanandam BP, Hoskinson SM, Eaves-Pyles T. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2018 03; 62(3).
-
Teleb M, Soto-Ruiz E, Dominguez DC, Antony S. ESBL E coli and P. aeruginosa Resistance to Ceftolozane-Tazobactam in a Patient with a Liver Abscess. The Search for an Omnipotent Antibiotic Goes On! Infect Disord Drug Targets. 2018; 18(1):81-85.
-
Y?bar MN, Curi-Pesantes B, Torres CA, Calder?n-Anyosa R, Riveros M, Ochoa TJ. [Multiresistance and factors associated with the presence of extended-spectrum beta-lactamases in Escherichia coli strains isolated from urine culture]. Rev Peru Med Exp Salud Publica. 2017 Oct-Dec; 34(4):660-665.
-
Katz AR, Komeya AY, Kirkcaldy RD, Whelen AC, Soge OO, Papp JR, Kersh EN, Wasserman GM, O'Connor NP, O'Brien PS, Sato DT, Maningas EV, Kunimoto GY, Tomas JE. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. Clin Infect Dis. 2017 Sep 15; 65(6):918-923.
-
Martinez T, Martinez I, Vazquez GJ, Aquino EE, Robledo IE. Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance. J Med Microbiol. 2016 Aug; 65(8):784-792.